Pure Global

Concentration of Receptors With Affinity for Cannabidiol and Cannabinol and the Effect on Chronic Orofacial Pain of Muscle Origin - Trial NCT06405646

Access comprehensive clinical trial information for NCT06405646 through Pure Global AI's free database. This phase not specified trial is sponsored by Wroclaw Medical University and is currently Enrolling by invitation. The study focuses on Myalgia,Muscle Pain,Orofacial Pain,Headache, Tension,Headaches Muscular. Target enrollment is 102 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06405646
Enrolling by invitation
diagnostic test
Trial Details
ClinicalTrials.gov โ€ข NCT06405646
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Concentration of Receptors With Affinity for Cannabidiol and Cannabinol and the Effect on Chronic Orofacial Pain of Muscle Origin
The Influence of the Concentration of Receptors With Affinity for Cannabidol and Cannabinol on the Risk of Occurrence and Severity of Chronic Orofacial Pain of Muscle Origin

Study Focus

Blood CB1, CB2, TRPV-1 concentration measurement

Observational

diagnostic test

Sponsor & Location

Wroclaw Medical University

Wroclaw, Poland

Timeline & Enrollment

N/A

Jun 01, 2024

Dec 01, 2024

102 participants

Primary Outcome

Relationship between the concentration of receptors with affinity for Cannabidol and Cannabinol and the risk of occurrence and severity of chronic orofacial pain of muscle origin,Assessment of the occurrence of chronic orofacial pain of muscular origin assessed using the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) protocol.

Summary

The main aim of the presented project will be to examine the concentration of selected
 receptors (CB1, CB2, TRPV-1) showing affinity for binding to cannabidol (CBD) and cannabinol
 (CBN) in blood samples collected from people with chronic pain in the masticatory muscles and
 from people without this pain. Moreover, study participants will be examined by a qualified
 doctor, according to the validated and standardized international DC/TMD protocol (Diagnostic
 Criteria for Temporomandibular Disorders) and the criteria included in ICOP-1 (International
 Classification of Orofacial Pain, 1st edition). The nature and duration of pain,
 psychoemotional state and central sensitization (the phenomenon of increased reactivity of
 the nervous system to stimuli) will be determined using validated questionnaires. The
 obtained results will be subjected to statistical analysis in order to check the
 relationships between the examined parameters.

ICD-10 Classifications

Tension-type headache
Other specified headache syndromes
Myalgia
Headache
Other headache syndromes

Data Source

ClinicalTrials.gov

NCT06405646

Non-Device Trial